CAPSEY CLINICAL COMMUNICATIONS LIMITEDActive

Company number 09397535Private limited companyIncorporated 2015

Key figures

£333,132-0.2%
Net assets 2025/26
+11.1%
Average annual growth 2020/21–2025/26
0100 k200 k300 k400 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, CAPSEY CLINICAL COMMUNICATIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand133,931171,169223,967237,552278,056
Total assets223,733283,362336,371352,942347,276
Total liabilities16,48327,19127,89920,56515,167
Net assets / total equity207,572257,701309,619333,741333,132
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CAPSEY CLINICAL COMMUNICATIONS LIMITED

Company

CAPSEY CLINICAL COMMUNICATIONS LIMITED is a private limited company registered with Companies House under company number 09397535. It was incorporated on 20 Jan 2015. Its status is active. The registered office is in Bicester (OX26). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Net assets were £333,132, down 0.2% on the previous year. Cash at bank and in hand was £278,056. Total assets were £347,276 and total liabilities £15,167. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 3 Feb 2027.